Page last updated: 2024-08-17

ampicillin and quinupristin-dalfopristin

ampicillin has been researched along with quinupristin-dalfopristin in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	7 (63.64)	18.2507
2000's	4 (36.36)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Inoue, K; Inoue, M; Mitsuhashi, S; Okamoto, R; Okubo, T	1
Herrera-Insúa, I; Jacques-Palaz, K; Murray, BE; Rakita, RM	1
Chow, JW; Davidson, A; Sanford, E; Zervos, MJ	1
Deobaldia, J; Evans, PA; Norden, CW; Rhoads, S; Silber, JL	1
Messick, CR; Pendland, SL	1
Jorgensen, JH; McElmeel, ML	1
Aeschlimann, JR; Hershberger, E; Moldovan, T; Rybak, MJ	1
Fujita, N	1
Ahrén, IL; Forsgren, A; Karlsson, E; Riesbeck, K	1
Bethea, JA; Targos, PA; Walko, CM	1
Heo, ST; Ki, HK; Kiem, S; Ko, KS; Lee, JY; Moon, CS; Oh, WS; Peck, KR; Song, JH	1

Reviews

1 review(s) available for ampicillin and quinupristin-dalfopristin

Article	Year
[Vancomycin-resistant enterococci (VRE)]. Rinsho byori. The Japanese journal of clinical pathology, 2000, Volume: 48, Issue:11 Topics: Ampicillin; Animals; Bacteremia; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Enterococcus; Gentamicins; Humans; Immunocompromised Host; Risk Factors; Urinary Tract Infections; Vancomycin Resistance; Virginiamycin	2000

Other Studies

10 other study(ies) available for ampicillin and quinupristin-dalfopristin

Article	Year
Comparative in-vitro activity of RP 59500 against clinical bacterial isolates. The Journal of antimicrobial chemotherapy, 1992, Volume: 30 Suppl A Topics: Ampicillin; Cefotaxime; Erythromycin; Gram-Positive Cocci; Humans; In Vitro Techniques; Methicillin Resistance; Microbial Sensitivity Tests; Virginiamycin	1992
Intracellular activities of RP 59500 (quinupristin-dalfopristin) and sparfloxacin against Enterococcus faecium. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:4 Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Enterococcus faecium; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Neutrophils; Quinolones; Vancomycin; Virginiamycin	1996
Superinfection with Enterococcus faecalis during quinupristin/dalfopristin therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24, Issue:1 Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Coronary Artery Bypass; Diabetes Mellitus, Type 1; Drug Hypersensitivity; Endocarditis; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Humans; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Penicillins; Renal Dialysis; Staphylococcal Infections; Staphylococcus aureus; Superinfection; Vancomycin; Virginiamycin; Wound Infection	1997
In vitro susceptibilities of clinical isolates of vancomycin-resistant enterococci. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:6 Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Microbial Sensitivity Tests; Penicillins; Vancomycin; Virginiamycin	1997
In vitro activity of chloramphenicol alone and in combination with vancomycin, ampicillin, or RP 59500 (quinupristin/dalfopristin) against vancomycin-resistant enterococci. Diagnostic microbiology and infectious disease, 1997, Volume: 29, Issue:3 Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Cross Infection; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Vancomycin; Virginiamycin	1997
Activity of quinupristin/dalfopristin and its components against Haemophilus influenzae. The Journal of antimicrobial chemotherapy, 1997, Volume: 39 Suppl A Topics: Ampicillin; Anti-Bacterial Agents; Culture Media; Erythromycin; Haemophilus influenzae; Microbial Sensitivity Tests; Penicillins; Virginiamycin	1997
Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovafloxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:3 Topics: Ampicillin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Drug Therapy, Combination; Fluoroquinolones; Gentamicins; Glycopeptides; Lipoglycopeptides; Microbial Sensitivity Tests; Naphthyridines; Rifampin; Staphylococcus aureus; Sulbactam; Teicoplanin; Time Factors; Vancomycin; Virginiamycin	1999
Comparison of the antibacterial activities of ampicillin, ciprofloxacin, clarithromycin, telithromycin and quinupristin/dalfopristin against intracellular non-typeable Haemophilus influenzae. The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:6 Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Typing Techniques; Ciprofloxacin; Clarithromycin; Haemophilus influenzae; Humans; Intracellular Fluid; Ketolides; Macrolides; Microbial Sensitivity Tests; Tumor Cells, Cultured; Virginiamycin	2002
Treatment of vancomycin-resistant enterococcus with quinupristin/dalfopristin and high-dose ampicillin. The Annals of pharmacotherapy, 2004, Volume: 38, Issue:6 Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacteremia; Drug Therapy, Combination; Enterococcus faecium; Female; Humans; Leukemia, Myeloid, Acute; Neutropenia; Staphylococcal Infections; Vancomycin Resistance; Virginiamycin	2004
Synergy of arbekacin-based combinations against vancomycin hetero-intermediate Staphylococcus aureus. Journal of Korean medical science, 2006, Volume: 21, Issue:2 Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Bacterial; Drug Synergism; Humans; In Vitro Techniques; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Teicoplanin; Vancomycin; Virginiamycin	2006